Loading
Latest filing published 02 Mar 2026 for FibroBiologics, Inc., €11k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ruben A. Garcia discloses dealings in FibroBiologics, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 11 December 2025 and the latest from 27 February 2026.
On the market, this insider has only ever bought: 2 purchases, €52k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.
The record was last updated on 2 March 2026 with an open-market purchase (€11k) in FibroBiologics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations